Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

CLSD

Clearside Biomedical (CLSD)

Clearside Biomedical Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CLSD
FechaHoraFuenteTítuloSímboloCompañía
25/10/202107:51TipRanksBausch + Lomb, Clearside Bag FDA Approval for XIPERENASDAQ:CLSDClearside Biomedical Inc
25/10/202106:28Dow Jones NewsBausch Health, Clearside Get FDA Approval for XipereNASDAQ:CLSDClearside Biomedical Inc
25/10/202106:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLSDClearside Biomedical Inc
13/10/202106:05GlobeNewswire Inc.Clearside Biomedical Delivers Podium and Poster Presentations at the American Society of Retina Specialists (ASRS) Annual MeetingNASDAQ:CLSDClearside Biomedical Inc
04/10/202106:05GlobeNewswire Inc.Clearside Biomedical Announces Multiple Poster Presentations at the Retina Society 54th Annual Scientific MeetingNASDAQ:CLSDClearside Biomedical Inc
23/09/202116:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CLSDClearside Biomedical Inc
21/09/202106:05GlobeNewswire Inc.Clearside Biomedical Announces Completion of Dosing in Cohort 2 of Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) in Wet AMD PatientsNASDAQ:CLSDClearside Biomedical Inc
09/09/202106:05GlobeNewswire Inc.Clearside Biomedical Expands XIPERE™ License Agreement with Arctic Vision to Include Australia, New Zealand, India and ASEAN CountriesNASDAQ:CLSDClearside Biomedical Inc
23/08/202115:05GlobeNewswire Inc.Clearside Biomedical to Present at the Ophthalmology Futures European 2021 Virtual Retina ForumNASDAQ:CLSDClearside Biomedical Inc
15/08/202119:00PR Newswire (US)Arctic Vision Announces Expansion of License Territory for Suprachoroidal Space Injection Therapy ARVN001 to Include ASEAN Countries and IndiaNASDAQ:CLSDClearside Biomedical Inc
10/08/202115:05GlobeNewswire Inc.Clearside Biomedical Announces Second Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
04/08/202106:05GlobeNewswire Inc.Clearside Biomedical to Participate in Two Upcoming Investor Conferences in August 2021NASDAQ:CLSDClearside Biomedical Inc
27/07/202115:05GlobeNewswire Inc.Clearside Biomedical to Report Second Quarter 2021 Financial Results and Provide Corporate Update on Tuesday, August 10, 2021NASDAQ:CLSDClearside Biomedical Inc
17/06/202118:38TipRanksIs Clearside Stock a Buy Right Now? This Is What You Need to KnowNASDAQ:CLSDClearside Biomedical Inc
15/06/202106:05GlobeNewswire Inc.Clearside Biomedical Announces Positive Safety Results from Cohort 1 of OASIS Phase 1/2a Clinical Trial of CLS-AX (axitinib i...NASDAQ:CLSDClearside Biomedical Inc
09/06/202106:05GlobeNewswire Inc.Clearside Biomedical to Participate in Two Upcoming Investor Conferences in June 2021NASDAQ:CLSDClearside Biomedical Inc
02/06/202105:59PR Newswire (US)Bausch Health And Clearside Biomedical Announce U.S. FDA Filing Acceptance For XIPERE™ (triamcinolone acetonide suprachoroi...NASDAQ:CLSDClearside Biomedical Inc
17/05/202115:58Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CLSDClearside Biomedical Inc
17/05/202115:05GlobeNewswire Inc.Clearside Biomedical Announces First Quarter 2021 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
10/05/202106:05GlobeNewswire Inc.Clearside Biomedical Announces Multiple Poster Presentations at the Association for Research in Vision and Ophthalmology 2021...NASDAQ:CLSDClearside Biomedical Inc
04/05/202106:05GlobeNewswire Inc.Clearside Biomedical to Report First Quarter 2021 Financial Results and Provide Corporate Update on Monday, May 17, 2021NASDAQ:CLSDClearside Biomedical Inc
03/05/202106:05GlobeNewswire Inc.Clearside Biomedical Announces Resubmission of New Drug Application for XIPERE™ for Treatment of Macular Edema Associated w...NASDAQ:CLSDClearside Biomedical Inc
28/04/202108:24Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CLSDClearside Biomedical Inc
28/04/202106:04Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CLSDClearside Biomedical Inc
05/04/202106:05GlobeNewswire Inc.Clearside Biomedical to Present at the Needham Virtual Healthcare Conference and Wet AMD & DME Drug Development SummitNASDAQ:CLSDClearside Biomedical Inc
15/03/202108:13Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CLSDClearside Biomedical Inc
10/03/202115:05GlobeNewswire Inc.Clearside Biomedical Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
02/03/202106:05GlobeNewswire Inc.Clearside Biomedical Announces Completion of Patient Dosing in First Cohort of Phase 1/2a Clinical Trial of CLS-AX (axitinib ...NASDAQ:CLSDClearside Biomedical Inc
24/02/202106:05GlobeNewswire Inc.Clearside Biomedical to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update on Wednesday,...NASDAQ:CLSDClearside Biomedical Inc
23/02/202106:05GlobeNewswire Inc.Clearside Biomedical to Participate in Two Upcoming Investor Conferences in March 2021NASDAQ:CLSDClearside Biomedical Inc
 Showing the most relevant articles for your search:NASDAQ:CLSD

Su Consulta Reciente

Delayed Upgrade Clock